ANGPTL4 and ovarian carcinoma: ANGPTL4 expression has been linked to chemotherapy resistance in pancreatic cancer, glioblastoma, and ovarian cancer [12,18,19], and is also linked to anoikis resistance and cancer progression [11,12,20,21].